you are here: Home News Merck

Merck

Merck, Linde eye India for semiconductor-grade chemical, gas facilities: Report
Merck in pact for Chinese obesity drug in nearly $2 billion deal
Pharma giant Merck acquires Prometheus for nearly $11 billion: Report
Delhi hospital, Merck partner to improve access to head & neck, colorectal cancer care
Govt likely to float global tender for HPV vaccine in April; Merck, Serum Institute may participate
Organon seeks to bring innovative healthcare solutions for women: Anjan Sen, South Asia lead
Organon seeks to bring innovative healthcare solutions for women: Anjan Sen, South Asia lead
Molnupiravir more effective against Omicron, claims new study
Covid-19 | Molnupiravir shows more gains than risks, say experts
FDA panel backs first-of-a-kind COVID-19 pill from Merck
COVID-19: Is the hype around the oral drug Molnupiravir justified?
Explained | Pfizer v/s Merck: New anti COVID pill and its comparison
New COVID-19 pill cut hospital, death risk by 90%, says Pfizer
EU medicines agency starts review of Merck oral COVID drug
Merck asks US regulators to authorize promising anti-COVID pill
Merck’s COVID-19 drug can be a game-changer
Merck spends $11.5 billion for Acceleron, possible blockbuster drug
Coronavirus pandemic | Cipla to expand portfolio for COVID-19 drugs over next two months, says CFO
Ideas for profit | Lupin: Focus on inhalation & biosimilars to aid margins in medium term
Lupin: Focus on inhalation and bio-similars to aid margins in medium term
Merck says study shows COVID-19 drug causes quick reduction in virus
Merck to help produce J&J's COVID-19 vaccine
Coronavirus Vaccine | How Merck, a vaccine titan, lost the COVID race
Merck CEO Kenneth Frazier to retire on June 30; CFO Robert Davis to be new chief
US giant Merck stops development of two COVID-19 vaccine candidates

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Merck

Merck, Linde eye India for semiconductor-grade chemical, gas facilities: Report

Merck in pact for Chinese obesity drug in nearly $2 billion deal

Pharma giant Merck acquires Prometheus for nearly $11 billion: Report

Delhi hospital, Merck partner to improve access to head & neck, colorectal cancer care

Govt likely to float global tender for HPV vaccine in April; Merck, Serum Institute may participate

Organon seeks to bring innovative healthcare solutions for women: Anjan Sen, South Asia lead

Organon seeks to bring innovative healthcare solutions for women: Anjan Sen, South Asia lead

Molnupiravir more effective against Omicron, claims new study

Covid-19 | Molnupiravir shows more gains than risks, say experts

FDA panel backs first-of-a-kind COVID-19 pill from Merck

COVID-19: Is the hype around the oral drug Molnupiravir justified?

Explained | Pfizer v/s Merck: New anti COVID pill and its comparison

New COVID-19 pill cut hospital, death risk by 90%, says Pfizer

EU medicines agency starts review of Merck oral COVID drug

Merck asks US regulators to authorize promising anti-COVID pill

Merck’s COVID-19 drug can be a game-changer

Merck spends $11.5 billion for Acceleron, possible blockbuster drug

Coronavirus pandemic | Cipla to expand portfolio for COVID-19 drugs over next two months, says CFO

Ideas for profit | Lupin: Focus on inhalation & biosimilars to aid margins in medium term

Lupin: Focus on inhalation and bio-similars to aid margins in medium term

Merck says study shows COVID-19 drug causes quick reduction in virus

Merck to help produce J&J's COVID-19 vaccine

Coronavirus Vaccine | How Merck, a vaccine titan, lost the COVID race

Merck CEO Kenneth Frazier to retire on June 30; CFO Robert Davis to be new chief

US giant Merck stops development of two COVID-19 vaccine candidates